Patents by Inventor Hubert Pueschner

Hubert Pueschner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PROCESSES
    Publication number: 20090306072
    Abstract: A method of treating inflammatory diseases of the airways or intestines which comprises administering substances selected from the group consisting of: (a) quinazolines of general formula wherein A, B, C, D, X, Ra, Rb, Rc and n are as defined herein, (b) the compounds (1) 4-[(3-chloro-4-fluorophenyl)amino]-6-[(4-dimethylamino-cyclohexyl)amino]-pyrimido[5,4-d]pyrimidine, (2) 4-[(R)-(1-phenylethyl)amino]-6-(4-hydroxyphenyl)-7H-pyrrolo[2,3-d]pyrimidine, and (3) 4-{[3-chloro-4-(3-fluoro-4-benzyloxy)-phenyl]amino}-6-(5-{[(2-methanesulphonyl-ethyl)amino]methyl}-furan-2-yl)quinazoline or (d) the antibodies Cetuximab C225, Trastuzumab, ABX-EGF and Mab ICR-62, and (f) EGFR-antisense.
    Type: Application
    Filed: August 19, 2009
    Publication date: December 10, 2009
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Birgit JUNG, Hubert Pueschner
  • Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
    Publication number: 20070004720
    Abstract: The use of selected quinazolines for the treatment of diseases of the airways or lungs as well as other inflammatory diseases. Exemplary of the selected quinazolines are: (1) 4-[(3-chloro-4-fluoro-phenyl)amino]-6-[1-(tert.-butyloxycarbonyl)-piperidin-4-yloxy]-7-methoxy-quinazoline, (2) 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(trans-4-amino-cyclohexan-1-yloxy)-7-methoxy-quinazoline, and (3) 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(trans-4-methanesulphonylamino-cyclohexan-1-yloxy)-7-methoxy-quinazoline.
    Type: Application
    Filed: September 7, 2006
    Publication date: January 4, 2007
    Inventors: Birgit Jung, Hubert Pueschner
  • Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
    Publication number: 20050096332
    Abstract: The present invention relates to the use of selected quinazolines, the tautomers, stereoisomers and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, for preparing a pharmaceutical composition for the prevention or treatment of diseases of the airways or lungs as well as other inflammatory diseases.
    Type: Application
    Filed: October 18, 2004
    Publication date: May 5, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Birgit Jung, Hubert Pueschner
  • Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
    Publication number: 20050059661
    Abstract: The present invention relates to the use of selected quinazolines, the tautomers, stereoisomers and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, for preparing a pharmaceutical composition for the prevention or treatment of diseases of the airways or lungs as well as other inflammatory diseases.
    Type: Application
    Filed: July 27, 2004
    Publication date: March 17, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Birgit Jung, Hubert Pueschner
  • Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
    Publication number: 20030149062
    Abstract: A method of treating inflammatory diseases of the airways or intestines which comprises administering substances selected from the group consisting of:
    Type: Application
    Filed: January 29, 2003
    Publication date: August 7, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Birgit Jung, Hubert Pueschner